HRP950437B1 - N-substituted azabicycloheptane derivatives, their production and use - Google Patents

N-substituted azabicycloheptane derivatives, their production and use

Info

Publication number
HRP950437B1
HRP950437B1 HR950437A HRP950437A HRP950437B1 HR P950437 B1 HRP950437 B1 HR P950437B1 HR 950437 A HR950437 A HR 950437A HR P950437 A HRP950437 A HR P950437A HR P950437 B1 HRP950437 B1 HR P950437B1
Authority
HR
Croatia
Prior art keywords
pct
production
azabicycloheptane derivatives
date feb
substituted azabicycloheptane
Prior art date
Application number
HR950437A
Other languages
English (en)
Inventor
Gerd Steiner
Rainer Munschauer
Thomas Hoeger
Liliane Unger
Hans-Juergen Teschendorf
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6524943&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP950437(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Basf Ag filed Critical Basf Ag
Publication of HRP950437A2 publication Critical patent/HRP950437A2/xx
Publication of HRP950437B1 publication Critical patent/HRP950437B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/90—Benzo [c, d] indoles; Hydrogenated benzo [c, d] indoles
    • C07D209/92—Naphthostyrils

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Luminescent Compositions (AREA)
HR950437A 1994-08-04 1995-08-04 N-substituted azabicycloheptane derivatives, their production and use HRP950437B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4427647A DE4427647A1 (de) 1994-08-04 1994-08-04 N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung

Publications (2)

Publication Number Publication Date
HRP950437A2 HRP950437A2 (en) 1997-08-31
HRP950437B1 true HRP950437B1 (en) 2002-06-30

Family

ID=6524943

Family Applications (1)

Application Number Title Priority Date Filing Date
HR950437A HRP950437B1 (en) 1994-08-04 1995-08-04 N-substituted azabicycloheptane derivatives, their production and use

Country Status (29)

Country Link
US (1) US5753690A (pl)
EP (1) EP0775113B1 (pl)
JP (1) JPH10503504A (pl)
KR (1) KR970704685A (pl)
CN (1) CN1064959C (pl)
AT (1) ATE200482T1 (pl)
AU (1) AU699021B2 (pl)
BG (1) BG63632B1 (pl)
CA (1) CA2196700A1 (pl)
CZ (1) CZ289080B6 (pl)
DE (2) DE4427647A1 (pl)
DK (1) DK0775113T3 (pl)
ES (1) ES2156212T3 (pl)
FI (1) FI970449A (pl)
GR (1) GR3035744T3 (pl)
HR (1) HRP950437B1 (pl)
HU (1) HUT77768A (pl)
IL (1) IL114719A (pl)
MX (1) MX9700854A (pl)
NO (1) NO307376B1 (pl)
NZ (1) NZ290429A (pl)
PL (1) PL182810B1 (pl)
PT (1) PT775113E (pl)
RU (1) RU2160254C2 (pl)
SI (1) SI9520086B (pl)
TW (1) TW378203B (pl)
UA (1) UA44736C2 (pl)
WO (1) WO1996004245A1 (pl)
ZA (1) ZA956476B (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836404A1 (de) * 1998-08-12 2000-02-17 Basf Ag N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
DE19836406A1 (de) * 1998-08-12 2000-02-17 Basf Ag N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
US6458821B1 (en) 1998-08-12 2002-10-01 Abbott Laboratories N-substituted azabicycloheptane derivatives, production and use thereof
DE19854147A1 (de) * 1998-11-24 2000-05-25 Basf Ag Verwendung von N-substituierten Azabicycloalkan-Derivaten zur Verwendung bei der Bekämpfung der Cocainsucht
WO2006040176A1 (en) * 2004-10-14 2006-04-20 Abbott Gmbh & Co. Kg Azabicycloheptyl compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
EP1874801A4 (en) * 2005-03-07 2009-03-25 Univ North Carolina RECA ACTIVITY INHIBITORS TO CONTROL ANTIBIOTIC-RESISTANT BACTERIAL PATHOGENS
FR2953514B1 (fr) * 2009-12-09 2011-12-23 Servier Lab Nouveaux derives azabicyclo[3.2.0]hept-3-yl, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
EP3978497A4 (en) * 2019-05-30 2022-07-13 Shanghai Institute of Materia Medica, Chinese Academy of Sciences FUSED CYCLIC COMPOUND, METHOD FOR PREPARING IT AND ITS USE
CN118356426A (zh) * 2023-01-18 2024-07-19 苏州旺山旺水生物医药股份有限公司 一种包含并环化合物的药物组合物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4243287A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-Substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
DE4219973A1 (de) * 1992-06-19 1993-12-23 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung
GB9321481D0 (en) * 1993-10-18 1993-12-08 Alcan Int Ltd Tin oxide
DE4341402A1 (de) * 1993-12-04 1995-06-08 Basf Ag N-substituierte Azabicycloheptan-Derivate, ihre Herstellung und Verwendung

Also Published As

Publication number Publication date
RU2160254C2 (ru) 2000-12-10
NO970474L (no) 1997-04-01
NZ290429A (en) 1998-02-26
CN1064959C (zh) 2001-04-25
SI9520086B (sl) 2002-02-28
DK0775113T3 (da) 2001-05-07
GR3035744T3 (en) 2001-07-31
ATE200482T1 (de) 2001-04-15
CN1156989A (zh) 1997-08-13
CZ289080B6 (cs) 2001-10-17
NO307376B1 (no) 2000-03-27
KR970704685A (ko) 1997-09-06
HUT77768A (hu) 1998-08-28
TW378203B (en) 2000-01-01
ZA956476B (en) 1997-02-03
EP0775113B1 (de) 2001-04-11
CA2196700A1 (en) 1996-02-15
PL182810B1 (pl) 2002-03-29
IL114719A (en) 2001-03-19
HRP950437A2 (en) 1997-08-31
IL114719A0 (en) 1995-11-27
BG101221A (en) 1997-08-29
SI9520086A (en) 1997-08-31
DE4427647A1 (de) 1996-02-08
PT775113E (pt) 2001-09-28
NO970474D0 (no) 1997-02-03
UA44736C2 (uk) 2002-03-15
US5753690A (en) 1998-05-19
AU3116595A (en) 1996-03-04
PL318459A1 (en) 1997-06-09
FI970449A0 (fi) 1997-02-03
DE59509186D1 (de) 2001-05-17
JPH10503504A (ja) 1998-03-31
CZ31197A3 (en) 1997-10-15
MX9700854A (es) 1997-04-30
EP0775113A1 (de) 1997-05-28
FI970449A (fi) 1997-04-03
ES2156212T3 (es) 2001-06-16
WO1996004245A1 (de) 1996-02-15
AU699021B2 (en) 1998-11-19
BG63632B1 (bg) 2002-07-31

Similar Documents

Publication Publication Date Title
IL111861A0 (en) N-substituted azabicycloalkane derivatives
AU3115395A (en) Dihydrobenzofuranes
AU2797695A (en) Thiazolidine derivatives, their preparation and drugs containing same
BR9509970A (pt) Composto
IL111862A0 (en) N-substituted azabicycloheptane derivatives
HRP950437B1 (en) N-substituted azabicycloheptane derivatives, their production and use
ZA957525B (en) Anthracycline derivatives
TW261614B (pl)
AU693241B2 (en) New 3-substituted 3h-2,3-benzodiazepine derivatives, their preparation and use as medicaments

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20010804

Year of fee payment: 7

B1PR Patent granted
PBON Lapse due to non-payment of renewal fee

Effective date: 20020805